Skip to main content
. 2018 Nov 23;110:11–16. doi: 10.1016/j.jcv.2018.11.006

Table 2.

Comparison of Medication Administrations, Chest X-rays, Turn-around-Time, and LOS by MRP Assay Type.

Unadjusted
Adjusted b
Luminex Biofire p-value a OR (95% CI) p-value
Empiric antibiotics -- no. (%) 646 (51.1%) 1239 (32.0%) <.001 0.45 (0.39, 0.52) <.001
Empiric broad-spectrum 447 (35.4%) 829 (21.4%) <.001 0.50 (0.43, 0.58) <.001
Broad-spectrum duration (hours) c -- median [IQR] 32.9 [22.9, 45.8] 6.4 [1.9, 13.2] <.001 --- ---
Empiric narrow-spectrum -- no. (%) 382 (30.2%) 625 (16.1%) <.001 0.44 (0.38, 0.52) <.001
Narrow-spectrum duration (hours) c-- median [IQR] 31.4 [18.1, 43.4] 9.1 [6.1, 16.3] <.001 --- ---
Oseltamivir post-test d -- no. (%) 23 (19.3%) 124 (79.0%) <.001 13.56 (7.29, 25.20) <.001
Chest x-rays within 48 hours of admission 803 (63.5%) 2245 (57.9%) <.001 0.71 (0.62, 0.82) <.001
Length of stay (hours) -- median [IQR] 54.3 [38.6, 89.0] 49.0 [32.2, 78.9] <.001 --- ---
Turn-around-time (hours) 27.1 [24.7, 50.3] 1.4 [1.2, 1.7] <.001 --- ---

Abbreviation: IQR, inter-quartile range; OR, odds ratio; CI, confidence interval.

a

Based on Fisher's Exact test for categorical and Kruskal-Wallis test for continuous.

b

Odds relative to Luminex after adjusting for patient age, organism, location, and calendar quarter.

c

Among patients with more than one empiric antibiotic administration.

d

Among patients positive for influenza.